Skye Bioscience, Inc. Net Cash Provided by (Used in) Investing Activities, Continuing Operations
Skye Bioscience, Inc. (SKYE) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of -$1.06 thousand for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-15.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2018-05-15
- Skye Bioscience, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2018-03-31 was -$1.06K.
- Skye Bioscience, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-12-31 was -$1.00.
- Skye Bioscience, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-09-30 was $0.00.
- Skye Bioscience, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-06-30 was $0.00.
- Skye Bioscience, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2017 was -$19.65K.
- Skye Bioscience, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2016 was -$11.12K.
- Skye Bioscience, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2015 was -$1.98K.
- Skye Bioscience, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2014 was -$23.26K.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month as first filed | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month as first filed | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 25 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 29 month |
|---|---|---|---|---|---|---|---|---|
| 2018-03-31 | -$1.06K 10-Q · filed 2018-05-15 | |||||||
| 2017-12-31 | -$19.65K 10-K · filed 2018-03-19 | |||||||
| 2016-12-31 | -$1.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-19 | -$1.00 derived: sum of 2 quarters · filed 2018-03-19 | -$1.00 derived: sum of 3 quarters · filed 2018-03-19 | -$11.12K 10-K · filed 2018-03-19 | ||||
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | $0.00 derived: sum of 2 quarters · filed 2017-11-14 | -$11.12K 10-Q · filed 2017-11-14 | -$11.12K derived: sum of 4 quarters · filed 2017-11-14 | ||||
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-11 | -$11.12K 10-Q · filed 2017-08-11 | -$11.12K derived: sum of 3 quarters · filed 2017-08-11 | |||||
| 2016-03-31 | -$11.12K 10-Q · filed 2017-05-12 | -$11.12K derived: sum of 2 quarters · filed 2017-05-12 | ||||||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-10 | -$1.98K 10-K · filed 2017-03-10 | ||||||
| 2015-09-30 | -$1.98K 10-Q · filed 2016-11-09 | |||||||
| 2014-12-31 | -$10.87K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-21 | -$23.26K 10-K · filed 2016-03-21 | ||||||
| 2014-09-30 | -$12.39K 10-Q · filed 2015-11-12 | |||||||
| 2014-07-31 | -$67.83K 10-Q · filed 2014-09-15 | |||||||
| 2013-10-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-01-27 | $11.00K derived: sum of 2 quarters · filed 2014-09-15 | $9.36K derived: sum of 3 quarters · filed 2014-09-15 | -$38.12K 10-K · filed 2014-01-27 | ||||
| 2013-07-31 | $11.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-09-15 | $9.36K derived: sum of 2 quarters · filed 2014-09-15 | -$38.12K 10-Q · filed 2014-09-15 | -$59.98K 10-Q · filed 2013-09-16 | -$69.55K 10-Q · filed 2013-09-16 | |||
| 2013-04-30 | -$1.65K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-06-05 | -$49.12K 10-Q · filed 2014-06-05 | -$64.54K 10-Q · filed 2013-06-27 | -$74.12K 10-Q · filed 2013-06-27 | ||||
| 2013-01-31 | -$47.47K 10-Q · filed 2014-03-17 | |||||||
| 2012-07-31 | $652.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-09-16 | $2.60K 10-Q · filed 2013-09-16 | ||||||
| 2012-04-30 | $1.95K 10-Q · filed 2013-06-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |